Home » Stocks » Apollo Endosurgery

Apollo Endosurgery, Inc. (APEN)

Stock Price: $1.44 USD -0.06 (-4.00%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 30.52M
Revenue (ttm) 39.61M
Net Income (ttm) -32.36M
Shares Out 23.68M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $1.44
Previous Close $1.50
Change ($) -0.06
Change (%) -4.00%
Day's Open 1.52
Day's Range 1.38 - 1.52
Day's Volume 26,405
52-Week Range 1.24 - 3.79

More Stats

Market Cap 30.52M
Enterprise Value 67.06M
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date n/a
Shares Outstanding 23.68M
Float 13.07M
EPS (basic) -1.53
EPS (diluted) -1.53
FCF / Share -1.28
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 373,994
Short Ratio 5.03
Short % of Float 1.07%
Beta 1.17
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.77
PB Ratio 5.89
Revenue 39.61M
Operating Income -27.51M
Net Income -32.36M
Free Cash Flow -26.98M
Net Cash -36.54M
Net Cash / Share -1.72
Gross Margin 64.82%
Operating Margin -69.46%
Profit Margin -81.70%
FCF Margin -68.12%
ROA -22.95%
ROE -867.87%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$5.00*
(247.22% upside)
Low
2.00
Current: $1.44
High
8.00
Target: 5.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue50.7160.8564.3164.6567.795.087.996.699.397.84
Revenue Growth-16.66%-5.37%-0.53%-4.63%1234.33%-36.39%19.42%-28.75%19.8%-
Gross Profit25.6833.1939.7339.4047.285.087.996.699.397.84
Operating Income-23.51-32.32-22.48-22.61-17.35-17.81-7.59-5.56-3.71-4.49
Net Income-27.43-45.79-27.29-41.17-27.43-16.56-6.56-2.75-3.11-4.60
Shares Outstanding21.5419.7913.570.390.240.220.170.140.120.10
Earnings Per Share-1.27-2.31-2.01-105.69-151.90-77.00-37.73-20.02-26.95-43.12
Operating Cash Flow-25.62-23.12-13.32-12.90-16.01-15.19-13.15-8.318.06-3.59
Capital Expenditures-0.79-1.95-1.56-1.03-4.76-0.54-0.39-0.34-0.49-0.47
Free Cash Flow-26.41-25.07-14.88-13.93-20.77-15.72-13.54-8.667.57-4.05
Cash & Equivalents30.9225.0131.4220.0422.5917.2811.8524.6214.416.80
Total Debt53.0021.1933.3239.4369.80-----
Net Cash / Debt-22.083.82-1.90-19.39-47.2217.2811.8524.6214.416.80
Assets74.5874.4710910210520.9615.6727.1817.9423.84
Liabilities72.4645.6459.1559.7194.025.145.7012.2417.3120.83
Book Value2.1228.8349.9142.42-13415.829.9714.940.633.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Apollo Endosurgery, Inc.
Country United States
Employees 217
CEO K. Todd Newton

Stock Information

Ticker Symbol APEN
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: APEN

Description

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.